Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

D. Minor,S. P. Moores,J. Chan
DOI: https://doi.org/10.1016/j.gore.2017.09.009
2017-09-25
Gynecologic Oncology Reports
Abstract:
What problem does this paper attempt to address?